“We’re about maybe three weeks behind Europe. Maybe a month at the most, so we’re on a trajectory to look a lot like Europe as we enter the month of November, so I think things are going to get worse,” Gottlieb said “The density of the epidemic underway in European countries like France, Italy and the U.K. right now far exceeds what’s underway in the United States,” he said. “For the most part, it’s a little bad everywhere in the United States. It’s not really, really bad anywhere with the exception of maybe Wisconsin, the Dakotas, Utah.””We’re at the beginning of that steep part of the epidemic curve right now. I wouldn’t be surprised if we challenge 100,000 diagnosed cases this week.
We’ll certainly get above 90,000 towards the end of the week if all the states report,” said Gottlieb, who led the FDA from May 2017 to April 2019 in the Trump administration.
“What we should be doing is trying to implement things now that are easy, or easier, to get ahead to not wait for this to truly become very dense. My concern is that we’re not doing that,” Gottlieb said.
Dr. Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic-testing start-up Tempus and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings′ and Royal Caribbean’s Healthy Sail Panel.